Company / SG&A Expense
ORAGENICS INC SG&A Expense History
FY2013-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$6.4M
FY2024
5-year range
$4.0M / $6.4M
FY2020-FY2024
Trend
+43.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $5M to $6M over the past 2 years.
Based on SEC 10-K filings.
$6M in FY2024 with a 10-year CAGR of +6.9%.
Increased from $5M to $6M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +6.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- +6.9%
Key checks
Key Insights
- 3-year CAGR of +6.9%, indicating consistent growth.
- In FY2024, sg&a expense increased 43.9% year-over-year.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -147.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.4M | +43.9% |
| FY2023 | $4.5M | -15.0% |
| FY2022 | $5.3M | +0.0% |
| FY2021 | $5.3M | +31.1% |
| FY2018 | $4.0M | +6.2% |
| FY2017 | $3.8M | +24.3% |
| FY2016 | $3.0M | -8.3% |
| FY2015 | $3.3M | +0.0% |
| FY2014 | $3.3M | -33.9% |
| FY2013 | $5.0M | +0.0% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026